Access to Avonex, Betaseron, & Copaxone




THE NAME GAME
Who gives general patient support?
A: The Avonex Support Line 800-456-2255 8:30 AM - 8 PM, E.T., M-F
B: MS Pathways (BetaSeron) 800-788-1467 8 AM - 8 PM, E.T., M-F
C: Shared Solutions (Copaxone) 800-887-8100 8 AM - 11 PM, E.T., M-F


Who does reimbursement and insurance counseling?
A: Support Line for the Avonex Access Program
B: MS Pathways OR The Betaseron Foundation
C: Reimbursement Services Group of Shared Solutions


TO BE ACCEPTED
Who determines eligibility for free or reduced price drug?
A: Covance Health Economics for the Avonex Access Program
B: The Betaseron Foundation
C: The Patient Assistance Program at NORD for Teva Marion Partners
Note:   The 3 access programs accept referrals by reimbursement counselors. A search for existing or potential benefits is always made first.


Approximate income cutoff
A: $60,000/year
B: 3 1/2 x the federal poverty level (for a person in a family of 4, $58,450/year)
C: None set


Means test
A: 1-page form and tax return, reviewed by Covance Health Economics
B: 3-page form and tax return or other income verification, reviewed by Lash Group
C: 6-page form, tax return, 3 months of bank statements, reviewed by NORD


% of completed applications approved    Estimated number of participants
A: 99%    A: 5,700 since 1997
B: 91%    A: 8,900 since 1994
C: 99%    A: 2,450 since 1997


THE GOODS
What do applicants who qualify receive?
A: Partly free to free Avonex
B: Free Betaseron
C: 25% to 100% of yearly Copaxone free


How?
A: By mail from Nova Factor, a direct delivery pharmacy
B: At local retail pharmacist
C: By mail from Caremark, a direct delivery pharmacy


Participation/shipping fees?
A: $25 shipping fee for a 3-month supply
B: $0 to $25/month determined by The Foundation, based on income
C: $0 to $25/month determined by Caremark, based on shipping cost


THE BIG PICTURE
 
Approximate number of people taking A, B, or C in 1999:   75,800
 
Approximate number receiving free or subsidized drug since access programs began:   17,050
 
Note: Data in these charts reflect reports by the respective parent pharmaceutical company and are their responsibility. No independent audit has been conducted.




~~click on the names below to go to the respective home page~~


Information in chart compliments of
InsideMS, Accessing the abc's,
winter 2000 edition
National Multiple Sclerosis Society



e-mail me here



Return to MS index page


This page was created 7-13-2000.
Everything within the home.earthlink.net/~sswats site is
© Copyright 1999 - 2002, S. E. Swatsenbarg and represents my work, except where noted.